RecruitingNot Applicable

Articaine Plus Dexmedetomidine in Supraclavicular Block

Egypt66 participantsStarted 2024-02-01

Plain-language summary

Articaine has emerged as a local anesthetic (LA) that produces sensory and motor blockade shorter than bupivacaine and lower in neurotoxicity than lidocaine. Studies have shown that adding dexmedetomidine to LA produces prolongation of sensory and motor bock duration. Early regain of motor power with adequate analgesia is needed in ambulatory surgery, for early start of physiotherapy. This study was designed to test efficacy of adding dexmedetomidine to articaine on the duration of sensory and motor block.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * aged 18-60 years planned for upper limb surgery below the midhumerus with an expected time of less than 90 min usually under tourniquet. Exclusion Criteria: * allergies to local anesthetic, * those with ASA III and IV, * patients who refuse to participate, * uncooperative patients, * patients who have infection at the site of injection, * patients who have bleeding disorder, and patients on anticoagulant drugs.

What they're measuring

Sensory block duration

Timeframe: 24 hours post block

Trial details

NCT IDNCT06423859

SponsorBenha University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-01

Contact for this trial

Samar R Amin, MD

+201287793991 samar.rafik@gmail.com

View on ClinicalTrials.gov More Post Operative Pain, Acute trials